Malejodejo, Mary Jane P.
HRN: 23-13-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2023
AMPICILLIN 1GM (VIAL)
06/06/2023
06/09/2023
IVT
2g
Q6H
PROM
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes